Chen Yung-Hsuan, Luo Sheng-Dean, Wu Shao-Chun, Wu Ching-Nung, Chiu Tai-Jan, Wang Yu-Ming, Yang Yao-Hsu, Chen Wei-Chih
Department of Otolaryngology, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung 833, Taiwan.
Department of Anesthesiology, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung 833, Taiwan.
Cancers (Basel). 2022 Aug 4;14(15):3795. doi: 10.3390/cancers14153795.
Purpose: To investigate the clinical characteristics, risk factors, and clinical outcomes of long-latent recurrence (>five years) of nasopharyngeal carcinoma (NPC). Methods: This retrospective study enrolled newly diagnosed NPC patients from the Chang Gung Research Database between January 2007 and December 2019. We analyzed the patients’ characteristics and survival outcomes after recurrence. Results: A total of 2599 NPC patients were enrolled. The overall recurrence rate was 20.5%, while 8.1% of patients had long-latent recurrence (>five years). These patients had a higher percentage of initial AJCC (The American Joint Committee on Cancer) stage I/II (60.5%, p = 0.001) and local recurrence (46.5%, p < 0.001). Unresectable rT3 and rT4 were found in 60% of patients when recurrence and 30% of local recurrence occurred in the skull base, which could not be detected by the regular endoscopy. The five-year overall survival rate of long-latent recurrence was 19.7%. Alive patients tended to be asymptomatic but have regular follow-ups with the interval less than six months. Multivariate analysis showed age and initial advanced AJCC stages were independent risk factors of death after recurrence. In contrast, patients with recurrence between two and five years, salvage surgeries, and regional recurrence had favorable survival outcomes. Conclusion: Long-latent NPC recurrence is not rare, and the survival outcome is poor. Regular follow-up for early detection of NPC recurrence is necessary even after five years of disease-free period.
探讨鼻咽癌(NPC)长潜伏期复发(>5年)的临床特征、危险因素及临床结局。方法:本回顾性研究纳入了2007年1月至2019年12月长庚研究数据库中初诊的NPC患者。我们分析了患者复发后的特征及生存结局。结果:共纳入2599例NPC患者。总复发率为20.5%,其中8.1%的患者有长潜伏期复发(>5年)。这些患者初始美国癌症联合委员会(AJCC)I/II期的比例更高(60.5%,p = 0.001),且局部复发率更高(46.5%,p < 0.001)。复发时60%的患者及局部复发发生在颅底时30%的患者存在不可切除的rT3和rT4,常规内镜检查无法检测到。长潜伏期复发患者的5年总生存率为19.7%。存活患者往往无症状,但定期随访,随访间隔小于6个月。多因素分析显示年龄和初始AJCC晚期是复发后死亡的独立危险因素。相比之下,复发时间在2至5年、接受挽救性手术及区域复发的患者生存结局较好。结论:鼻咽癌长潜伏期复发并不罕见,且生存结局较差。即使在无病期5年后,定期随访以早期发现鼻咽癌复发也是必要的。